Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 June 2023 | Story Melissa Kilian | Photo Supplied
Melissa Kilian
Melissa Kilian is a Lecturer in the Department of Occupational Therapy.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Melissa Kilian, Lecturer in the Department of Occupational Therapy, shares her UFS journey:

Q: Year of graduation from the UFS:

A: 2011 and 2021.

Q: Qualification obtained from the UFS:

A: Baccalaureus and Master of Occupational Therapy.

Q: Date of joining the UFS as a staff member:

A: 1 June 2022 (employed for one year this month).

Q: Initial job title and current job title:

A: Lecturer in Occupational Therapy.

Q: How did the UFS prepare you for the professional world?

A: The UFS provided me with excellent clinical exposure to the diverse profession of occupational therapy. Additionally, the occupational therapy undergraduate course provided many opportunities for promoting self-awareness and self-development and entering the workforce as a graduate willing to explore the dimensions of the profession and what my unique contribution can be.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: Since being employed with the UFS, I have a deeper acknowledgement and appreciation for lecturers, as well as a multi-layered understanding of the importance of curriculum development and how this translates into students becoming competent graduates.

Q: Any additional comments about your experience?

A: It’s been quite an experience ...!

News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept